Progression of Liver Lesions Produced in Rats by Temporary Treatment with Pyrrolizidine (Senecio) Alkaloids, and the Effects of Betaine and High Casein Diet
1957

Liver Lesions in Rats from Pyrrolizidine Alkaloids

Sample size: 82 publication Evidence: moderate

Author Information

Author(s): Regina Schoental, Mary A. Head

Primary Institution: Royal Beatson Memorial Hospital, Glasgow

Hypothesis

Can temporary treatment with pyrrolizidine alkaloids lead to liver lesions in rats, and what is the effect of betaine and high casein diet on these lesions?

Conclusion

The study found that liver lesions produced by pyrrolizidine alkaloids are irreversible and progressive, regardless of dietary supplements.

Supporting Evidence

  • Liver lesions developed in rats treated with pyrrolizidine alkaloids.
  • High casein diet did not prevent liver lesions.
  • Betaine supplementation did not inhibit liver tumor development.
  • Lesions became more pronounced over time after treatment ceased.
  • Some liver lesions were similar to hepatomas.
  • Male rats showed greater susceptibility to liver damage than females.
  • Control rats showed no significant liver abnormalities.

Takeaway

Rats treated with certain plant chemicals developed serious liver problems that got worse over time, even after stopping the treatment.

Methodology

Young Wistar rats were treated with pyrrolizidine alkaloids and observed for liver lesions, with some receiving dietary supplements.

Potential Biases

Potential bias in the selection of dietary treatments and the interpretation of liver lesion severity.

Limitations

The study primarily focused on male rats, and the long-term effects on female rats were less emphasized.

Participant Demographics

Young Wistar rats, both male and female.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication